PUBLIC CONTRACT · 2017
050104812017Aquisição de Medicamentos pelo SPMS C2026- CERTOLIZUMAB PEGOL(200MG/1ML,SOL.INJ. SERINGA
- Contract value
- €28,360.00
- Signed on
- 21 March 2017
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4456154PUBLISHED SUBJECT
050104812017Aquisição de Medicamentos pelo SPMS C2026- CERTOLIZUMAB PEGOL(200MG/1ML,SOL.INJ. SERINGA
Parties involved
- Place of performance
- Portugal, Coimbra, Coimbra
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- UCB PHARMA (PRODUTOS FARMACEUTICOS), LDA · Tax ID 500291322
Values and timeline
- Contract price
- €28,360.00
- Procedure base price
- €0.00
- Total effective price
- €28,360.00
- Publication date
- 9 May 2018
- Award date
- 17 February 2017
- Signing date
- 21 March 2017
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33698000-9 - Produtos para fins clínicos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3389823
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.